55824-11-8

Basic information

• Product Name: Cannabigerovarol
• Synonyms: 2-[(E)-3,7-Dimethyl-2,6-octadienyl]-5-propyl-1,3-benzenediol;Cannabigerovarin;Cannabigerovarol
• CAS NO: 55824-11-8
• Molecular Formula: C₁₉H₂₈O₂
• Molecular Weight: 288.42442
• Mol File: 55824-11-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 445.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.003±0.06 g/cm3(Predicted)
• PKA: 9.68±0.40(Predicted)
• CAS DataBase Reference: Cannabigerovarol(CAS DataBase Reference)
• NIST Chemistry Reference: Cannabigerovarol(55824-11-8)
• EPA Substance Registry System: Cannabigerovarol(55824-11-8)

Safety Data

• Hazardous Substances Data: 55824-11-8(Hazardous Substances Data)

Usage

Description

Cannabigerovarol (CBGV) is a minor cannabinoid found in cannabis plants, structurally related to other cannabinoids such as cannabigerol (CBG) and cannabidiol (CBD). It is a non-psychoactive compound with potential therapeutic benefits, including anti-inflammatory, neuroprotective, and anti-cancer properties. Further research is needed to fully understand its pharmacological properties and potential medical applications.

Uses

Used in Pharmaceutical Industry:
Cannabigerovarol is used as a therapeutic agent for its potential anti-inflammatory, neuroprotective, and anti-cancer properties. It may help in managing inflammation, protecting the nervous system, and fighting cancer cells.
Used in Cosmetic Industry:
Cannabigerovarol is used as an ingredient in cosmetic products for its potential anti-inflammatory and skin-soothing properties, making it suitable for skincare formulations.
Used in Nutraceutical Industry:
Cannabigerovarol is used as a supplement in the nutraceutical industry for its potential health benefits, including its anti-inflammatory and neuroprotective properties.
Used in Drug Development:
Cannabigerovarol is used in drug development for its potential therapeutic benefits, with ongoing research to explore its pharmacological properties and medical applications further.

Upstream product

• 64924-07-8 6-carboxylic acid-2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propyl-benzene-1,3-diol 
• 106-24-1 Geraniol 
• 500-49-2 5-propyl-1,3-benzenediol 
• 156567-57-6 propylzinc bromide 
• 108-73-6 3,5-dihydroxyphenol 

Downstream Products

• 64924-07-8 6-carboxylic acid-2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propyl-benzene-1,3-diol 

Relevant articles and documents

CATALYTIC CANNABIGEROL PROCESSES AND PRECURSORS

The present disclosure relates to cannabigerol sulfonate esters and processes for their use to prepare cannabigerol (CBG) and related compounds, including cannabigerobutol (CBGB), cannabigerovarin (CBGV), and cannabigerophorbol (CBGP). In a preferred embodiment, the cannabigerol sulfonate ester is (E)-4-(3, 7-5 dimethylocta-2,6-dienyl)-3,5-bis(trimetbylsilyloxy)phenyl trifluoromethanesulfonate. In a preferred process, the trifluoromethansulfonate leaving group is replaced by an alkyl group. The disclosure also relates to the use of catalysts and catalytic processes for the preparation of cannabigerol and related compounds from the cannabigerol sulfonate esters.

APPARATUS AND METHODS FOR THE SIMULTANEOUS PRODUCTION OF CANNABINOID COMPOUNDS

The present invention provides an apparatus and methods for simultaneously producing different compounds in various ratios under set conditions.

Cannabis. X. The isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai cannabis, Meao Variant

Four new cannabinoids acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid were isolated from Thai Cannabis 'Meao variant' and these structures were elucidated on the basis of chemical and spectral data. This is the first example of the isolation of propyl cannabinoid acid from Cannabis.